Work

Improve Access to Care for Opioid Use Disorder: A Call to Eliminate the X-Waiver Requirement Now

Year: 2021

Type: article

Abstract: At the dawn of a new presidential administration, we find ourselves at the crossroads of colliding crises. Action to curb the COVID-19 pandemic has been swift. We now call for similar action from the Federal Government in tackling the opioid epidemic by normalizing medication treatment for addiction. The opioid epidemic is escalating, with over 81,000 drug overdose deaths reported in the 12 months prior to May 2020,1 primarily driven by the rise in fentanyl use and compounded by the devastating effects of the COVID-19 pandemic, including social isolation, restrictions in treatment and harm reduction services, and disruptions in drug supply.

Source: Annals of Emergency Medicine

DOI: 10.1016/j.annemergmed.2021.03.023

Authors: Gail D’Onofrio, Edward R. Melnick, Kathryn F. Hawk

Institution: Yale University

Language: English

Topic: Opioid Use Disorder Treatment

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,000